Key points are not available for this paper at this time.
Our study aims to determine whether myostatin (MSTN) is associated with muscle mass and strength in individuals with cancer or obesity, as well as with cancer cachexia (CC) or sarcopenic obesity (SO).
Orioli et al. (Fri,) studied this question.